-+ 0.00%
-+ 0.00%
-+ 0.00%

ICECURE REPORTS UPDATED TIMELINE AND PROGRESS WITH FDA REGARDING MARKETING AUTHORIZATION FOR PROSENSE® CRYOABLATION IN EARLY-STAGE BREAST CANCER

Reuters·03/20/2025 12:30:52

Please log in to view news